ZT-01 aims to restore glucagon counterregulation during hypoglycaemia. But type 1 diabetes already produces glucagon at the wrong time — and Zucara’s own human data show SSTR2 blockade raises glucagon, glucose and insulin requirements during euglycaemia. What will the trials tell us about its longer term effects?
When you give an oref based hybrid closed loop minute by minute data, what happens to it’s insulin delivery choices? This is where we find out.
How much of a meal signal is there in glucose data, and what can you do with it? This article describes a deep dive into a large dataset and tells us what it finds.
An update on Boost, how it helps remove carb counting, and the techniques and mechanisms we’ve used to try and get there.
Embedded AI is starting to appear in open source AID systems, offered as copy and paste, bring your own key, or a service the project runs. A year of measuring these models says the clinical risk is much the same in all three. The regulatory position is not, and the intuition about which is safest runs backwards.
Ask once and you get an answer. Ask fifty times and you get eighteen different pairs of safety limits, a headline that flips one time in five, and an app that accepts them all. Inside the £4.49 app that turns your diabetes data into chatbot advice on your OS-AID settings.
Search the app stores for diabetes and AI and you will find a remarkable number of applications doing exactly one thing. You point a camera […]
A slightly rhetorical question, I’ll admit, but a pertinent one. Once again, I have been trying out the latest (read most heavily pushed on Facebook […]
Abbott has put glucose and ketones on the same wearable, and the launch coverage is all about DKA. Worth having if you’re on a pump, which is fine as far as it goes, but it misses the bit that makes this interesting. Because if you look at what Abbott has actually built across its other divisions, and what they’ve patented alongside it, the Libre Duo doesn’t really look like a ketone sensor. It looks like the platform prototype and the first visible piece of an infrastructure designed to move chronic disease care out of outpatients and into the home. And the policy environment for that shift has just been locked in on both sides of the Atlantic for the next five years.
We took Nightscout data from three people and gave it to 5 Large Language Models with a detailed prompt to see how they would respond.
The results weren’t what I was expecting.
Copyright © 2026 | WordPress Theme by MH Themes